Penicillin-binding proteins (PBPs)
make up an essential class of
bacterial enzymes that carry out the final steps of peptidoglycan
synthesis and regulate the recycling of this polymeric structure.
PBPs are an excellent drug target and have been the most clinically
relevant antibacterial target since the 1940s with the introduction
of β-lactams. Despite this, a large gap in knowledge remains
regarding the individual function and regulation of each PBP homologue
in most bacteria. This can be attributed to a lack of chemical tools
and methods that enable the study of individual PBPs in an activity-dependent
manner and in their native environment. The development of such methods
in Gram-negative bacteria has been particularly challenging due to
the presence of an outer membrane and numerous resistance mechanisms.
To address this, we have developed an optimized live-cell assay for
screening inhibitors of the PBPs in Escherichia coli MG1655. We utilized EDTA to permeabilize Gram-negative cells, enabling
increased penetration of our readout probe, Bocillin-FL, and subsequent
analysis of PBP-inhibition profiles. To identify scaffolds for future
development of PBP-selective activity-based probes, we screened ten
β-lactams, one diazabicyclooctane, and one monobactam for their
PBP-selectivity profiles in E. coli MG1655. These
results demonstrate the utility of our assay for the screening of
inhibitors in live, non-hypersusceptible Gram-negative organisms.